These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

439 related items for PubMed ID: 32032921

  • 1. Update on the pharmacologic management of narcolepsy: mechanisms of action and clinical implications.
    Thorpy MJ, Bogan RK.
    Sleep Med; 2020 Apr; 68():97-109. PubMed ID: 32032921
    [Abstract] [Full Text] [Related]

  • 2. Evaluating pitolisant as a narcolepsy treatment option.
    de Biase S, Pellitteri G, Gigli GL, Valente M.
    Expert Opin Pharmacother; 2021 Feb; 22(2):155-162. PubMed ID: 32941089
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Pitolisant, an inverse agonist of the histamine H3 receptor: an alternative stimulant for narcolepsy-cataplexy in teenagers with refractory sleepiness.
    Inocente C, Arnulf I, Bastuji H, Thibault-Stoll A, Raoux A, Reimão R, Lin JS, Franco P.
    Clin Neuropharmacol; 2012 Feb; 35(2):55-60. PubMed ID: 22356925
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. pitolisant, a novel histamine-3 receptor competitive antagonist, and inverse agonist, in the treatment of excessive daytime sleepiness in adult patients with narcolepsy.
    Sarfraz N, Okuampa D, Hansen H, Alvarez M, Cornett EM, Kakazu J, Kaye AM, Kaye AD.
    Health Psychol Res; 2022 Feb; 10(3):34222. PubMed ID: 35774905
    [Abstract] [Full Text] [Related]

  • 9. Update on therapy for narcolepsy.
    Thorpy MJ.
    Curr Treat Options Neurol; 2015 May; 17(5):347. PubMed ID: 25854650
    [Abstract] [Full Text] [Related]

  • 10. Narcolepsy in the older adult: epidemiology, diagnosis and management.
    Chakravorty SS, Rye DB.
    Drugs Aging; 2003 May; 20(5):361-76. PubMed ID: 12696996
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Emerging treatments for narcolepsy and its related disorders.
    Nishino S, Okuro M.
    Expert Opin Emerg Drugs; 2010 Mar; 15(1):139-58. PubMed ID: 20166851
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Profile of Solriamfetol in the Management of Excessive Daytime Sleepiness Associated with Narcolepsy or Obstructive Sleep Apnea: Focus on Patient Selection and Perspectives.
    Abad VC.
    Nat Sci Sleep; 2021 Mar; 13():75-91. PubMed ID: 33531850
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.